Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.4% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Technology | 6.04% |
| 4 | Industrials | 5.81% |
| 5 | Financials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KIN
3801
DELISTED
Kindred Biosciences, Inc.
KIN
| $294 | ﹤0.01% |
68,563
-753,189
| -92% | -$3.15M |
|
|
AKCA
3802
DELISTED
Akcea Therapeutics Inc
AKCA
| $294 | ﹤0.01% |
+16,219
| New | +$230K |
|
3803
CALL
Rocket Pharmaceuticals
RCKT
$340M
| $293 | ﹤0.01% |
+12,800
| New | +$315K |
|
|
CKPT
3804
DELISTED
Checkpoint Therapeutics
CKPT
| $292 | ﹤0.01% |
10,890
+1,278
| +13% | +$30.7K |
|
3805
NovaGold Resources
NG
$2.56B
| $292 | ﹤0.01% |
+24,562
| New | +$240K |
|
3806
Valhi
VHI
$380M
| $292 | ﹤0.01% |
22,153
-13,448
| -38% | -$161K |
|
3807
PUT
Simon Property Group
SPG
$74.4B
| $291 | ﹤0.01% |
4,500
-500
| -10% | -$32.8K |
|
3808
International General Insurance
IGIC
$1.19B
| $290 | ﹤0.01% |
40,594
-1,691
| -4% | -$11.4K |
|
3809
Itron
ITRI
$4.36B
| $290 | ﹤0.01% |
+4,767
| New | +$303K |
|
|
SRGA
3810
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $290 | ﹤0.01% |
5,345
-11,906
| -69% | -$911K |
|
3811
Tejon Ranch
TRC
$457M
| $289 | ﹤0.01% |
20,398
-40,308
| -66% | -$582K |
|
|
WTER
3812
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $289 | ﹤0.01% |
+15,314
| New | +$399K |
|
|
AAIC
3813
DELISTED
Arlington Asset Investment Corp.
AAIC
| $289 | ﹤0.01% |
101,705
-11,311
| -10% | -$31.8K |
|
|
IPHA
3814
Innate Pharma
IPHA
$164M
| $288 | ﹤0.01% |
72,657
| – | – |
|
3815
Bank7 Corp
BSVN
$479M
| $286 | ﹤0.01% |
30,462
-2,076
| -6% | -$20.9K |
|
3816
KT
KT
$8.62B
| $285 | ﹤0.01% |
29,634
-45,810
| -61% | -$457K |
|
|
LRFC
3817
DELISTED
Logan Ridge Finance Corp
LRFC
| $285 | ﹤0.01% |
+30,285
| New | +$372K |
|
3818
Malibu Boats
MBUU
$541M
| $285 | ﹤0.01% |
+5,760
| New | +$313K |
|
3819
China Yuchai International
CYD
$1.77B
| $284 | ﹤0.01% |
+15,796
| New | +$245K |
|
3820
Granite Construction
GVA
$5.29B
| $284 | ﹤0.01% |
16,150
-26,229
| -62% | -$480K |
|
3821
Ranpak Holdings
PACK
$439M
| $284 | ﹤0.01% |
+29,801
| New | +$265K |
|
3822
Clean Energy Fuels
CLNE
$427M
| $283 | ﹤0.01% |
113,988
-1,137,061
| -91% | -$2.96M |
|
3823
PUT
Moderna
MRNA
$21.8B
| $283 | ﹤0.01% |
+4,000
| New | +$279K |
|
3824
Howard Hughes
HHH
$3.81B
| $282 | ﹤0.01% |
5,142
-90,046
| -95% | -$4.81M |
|
3825
Stock Yards Bancorp
SYBT
$2.64B
| $282 | ﹤0.01% |
+8,297
| New | +$331K |
|
Similar funds
Millennium Management's Q3 2020 Portfolio in Review
As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Millennium Management opened 989 new positions and closed 724 in Q3 2020.
- Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.